 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hikal Consolidated September 2023 Net Sales at Rs 434.88 crore, down 22.17% Y-o-Y

Hikal Standalone September 2023 Net Sales at Rs 434.88 crore, down 22.17% Y-o-Y

Hikal Q2 earnings: The company had reported a consolidated net profit of Rs 6.92 crore in the first quarter of the current fiscal

Hikal Q2 results: Net profit tanks 49% to Rs 12.57 crore

Hikal announced that the 35th Annual General Meeting (AGM) of the company will be held on 26 September 2023.

Hikal to hold AGM

Hikal Consolidated June 2023 Net Sales at Rs 388.05 crore, up 2.44% Y-o-Y

Hikal Q1 results: Revenue came in at Rs 388.05 crore, 2.44 percent higher from the year-ago period

Hikal Q1 results: Pharma firm swings to Rs 6.92 crore profit

The share touched a 52-week high of Rs 427.95 and a 52-week low of Rs 244.95 on 03 January, 2023 and 11 August, 2022, respectively.

Hikal share price rises nearly 2% after GPCB withdrawn closure order

The company says it commitment to environmental norms remains unwavering and it is engaging with the pollution board to resolve the matter

Hikal down over 5% after Gujarat pollution board orders closure Bharuch unit

Smallcap index ended up forming “Harami” candlestick pattern on the daily charts, which creates some chances of resuming primary uptrend. However, confirmation will come by looking at the direction in which index opens on June 27.

Hot Stocks | Hikal, Firstsource Solutions, Mahindra Holidays can fetch up to 22% returns

Vinay Rajani believes that though the momentum has come down a bit in the Index, Nifty is still in to continuation of an uptrend.

Hot Stocks | Firstsource Solutions, Hikal, NESCO likely to return up to 16% in short term; here's why

Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. It operates through the Crop Protection and Pharmaceuticals segments. The Crop Protection segment involves in manufacturing of intermediates and active ingredients. The Pharmaceuticals segment offers contract development and manufacturing; APIs and intermediates; animal health, and project management. The company was founded by Jai Hiremath on July 8, 1988 and is headquartered in Mumbai, India.

Watchers	51
52-Wk Low	250.10
52-Wk High	427.80

Market Cap	35.71B
Volume (M)	130,329.00
52-Wk High	427.80
52-Wk Low	250.10

HIKAL.NSE Hikal Ltd.

About

Feed

News

Sentiment

Fundamentals